vs
三维系统（DDD）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
三维系统的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$106.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -18.4%，领先402.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -4.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 1.6%）
3D Systems是一家总部位于美国南卡罗来纳州罗克希尔的企业，核心业务涵盖3D打印机、3D打印材料的研发生产与销售，同时提供3D打印零部件定制及应用工程服务，可产品概念模型、精密功能原型、工裝母模以及直接数字化生产零部件等产品，服务各行各业的数字化制造需求。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DDD vs RIGL — 直观对比
营收规模更大
DDD
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出25.5%
-4.3%
净利率更高
RIGL
高出402.4%
-18.4%
两年增速更快
RIGL
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $106.3M | $69.8M |
| 净利润 | $-19.5M | $268.1M |
| 毛利率 | 30.8% | 91.5% |
| 营业利润率 | -21.3% | 33.2% |
| 净利率 | -18.4% | 384.0% |
| 营收同比 | -4.3% | 21.2% |
| 净利润同比 | 41.7% | 1769.2% |
| 每股收益（稀释后） | $0.04 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DDDRIGL
| Q4 25 | $106.3M | $69.8M | ||
| Q3 25 | $91.2M | $69.5M | ||
| Q2 25 | $94.8M | $101.7M | ||
| Q1 25 | $94.5M | $53.3M | ||
| Q4 24 | $111.0M | $57.6M | ||
| Q3 24 | $112.9M | $55.3M | ||
| Q2 24 | $113.3M | $36.8M | ||
| Q1 24 | $102.9M | $29.5M |
净利润DDDRIGL
| Q4 25 | $-19.5M | $268.1M | ||
| Q3 25 | $-18.1M | $27.9M | ||
| Q2 25 | $104.4M | $59.6M | ||
| Q1 25 | $-37.0M | $11.4M | ||
| Q4 24 | $-33.5M | $14.3M | ||
| Q3 24 | $-178.6M | $12.4M | ||
| Q2 24 | $-27.3M | $-1.0M | ||
| Q1 24 | $-16.0M | $-8.2M |
毛利率DDDRIGL
| Q4 25 | 30.8% | 91.5% | ||
| Q3 25 | 32.3% | 93.2% | ||
| Q2 25 | 38.1% | 95.6% | ||
| Q1 25 | 34.6% | 91.7% | ||
| Q4 24 | 31.0% | 89.9% | ||
| Q3 24 | 36.9% | 85.5% | ||
| Q2 24 | 41.6% | 92.4% | ||
| Q1 24 | 39.8% | 93.1% |
营业利润率DDDRIGL
| Q4 25 | -21.3% | 33.2% | ||
| Q3 25 | -23.4% | 40.9% | ||
| Q2 25 | -16.2% | 60.1% | ||
| Q1 25 | -38.9% | 23.9% | ||
| Q4 24 | -27.4% | 28.9% | ||
| Q3 24 | -160.0% | 25.4% | ||
| Q2 24 | -23.3% | 1.2% | ||
| Q1 24 | -38.7% | -23.6% |
净利率DDDRIGL
| Q4 25 | -18.4% | 384.0% | ||
| Q3 25 | -19.8% | 40.2% | ||
| Q2 25 | 110.1% | 58.6% | ||
| Q1 25 | -39.1% | 21.5% | ||
| Q4 24 | -30.1% | 24.9% | ||
| Q3 24 | -158.2% | 22.5% | ||
| Q2 24 | -24.1% | -2.8% | ||
| Q1 24 | -15.5% | -27.9% |
每股收益（稀释后）DDDRIGL
| Q4 25 | $0.04 | $14.11 | ||
| Q3 25 | $-0.14 | $1.46 | ||
| Q2 25 | $0.57 | $3.28 | ||
| Q1 25 | $-0.28 | $0.63 | ||
| Q4 24 | $-0.26 | $0.82 | ||
| Q3 24 | $-1.35 | $0.70 | ||
| Q2 24 | $-0.21 | $-0.06 | ||
| Q1 24 | $-0.12 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $95.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $240.4M | $391.5M |
| 总资产 | $521.7M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DDDRIGL
| Q4 25 | $95.6M | $155.0M | ||
| Q3 25 | $95.5M | $137.1M | ||
| Q2 25 | $116.4M | $108.4M | ||
| Q1 25 | $135.0M | $77.1M | ||
| Q4 24 | $171.3M | $77.3M | ||
| Q3 24 | $190.0M | $61.1M | ||
| Q2 24 | $192.7M | $49.1M | ||
| Q1 24 | $212.0M | $49.5M |
总债务DDDRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益DDDRIGL
| Q4 25 | $240.4M | $391.5M | ||
| Q3 25 | $221.1M | $117.6M | ||
| Q2 25 | $241.2M | $81.9M | ||
| Q1 25 | $145.6M | $18.6M | ||
| Q4 24 | $176.2M | $3.3M | ||
| Q3 24 | $218.0M | $-14.6M | ||
| Q2 24 | $381.7M | $-29.9M | ||
| Q1 24 | $408.4M | $-31.7M |
总资产DDDRIGL
| Q4 25 | $521.7M | $513.6M | ||
| Q3 25 | $554.5M | $242.5M | ||
| Q2 25 | $587.8M | $206.7M | ||
| Q1 25 | $583.4M | $176.0M | ||
| Q4 24 | $608.8M | $164.0M | ||
| Q3 24 | $658.3M | $139.4M | ||
| Q2 24 | $821.5M | $128.4M | ||
| Q1 24 | $857.2M | $126.5M |
负债/权益比DDDRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-16.6M | — |
| 自由现金流率自由现金流/营收 | -15.7% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-97.8M | — |
8季度趋势，按日历期对齐
经营现金流DDDRIGL
| Q4 25 | $-14.7M | $22.0M | ||
| Q3 25 | $-13.5M | $24.0M | ||
| Q2 25 | $-25.8M | $30.5M | ||
| Q1 25 | $-33.8M | $-893.0K | ||
| Q4 24 | $-7.8M | $14.5M | ||
| Q3 24 | $-801.0K | $21.7M | ||
| Q2 24 | $-10.8M | $302.0K | ||
| Q1 24 | $-25.5M | $-5.0M |
自由现金流DDDRIGL
| Q4 25 | $-16.6M | — | ||
| Q3 25 | $-15.8M | — | ||
| Q2 25 | $-28.8M | — | ||
| Q1 25 | $-36.6M | — | ||
| Q4 24 | $-13.1M | — | ||
| Q3 24 | $-4.4M | — | ||
| Q2 24 | $-14.7M | — | ||
| Q1 24 | $-28.7M | — |
自由现金流率DDDRIGL
| Q4 25 | -15.7% | — | ||
| Q3 25 | -17.3% | — | ||
| Q2 25 | -30.4% | — | ||
| Q1 25 | -38.7% | — | ||
| Q4 24 | -11.8% | — | ||
| Q3 24 | -3.9% | — | ||
| Q2 24 | -13.0% | — | ||
| Q1 24 | -27.9% | — |
资本支出强度DDDRIGL
| Q4 25 | 1.8% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 3.1% | — |
现金转化率DDDRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | -0.25× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DDD
| Products | $62.6M | 59% |
| Services | $43.7M | 41% |
RIGL
暂无分部数据
